Tag: Merck

Merck Secures $1.2B CARES Act funds for Antiviral TherapyContract Awards

Merck Secures $1.2B CARES Act funds for Antiviral Therapy

Army Contracting Command has awarded Merck (NYSE: MRK) a one-year, $1.2 billion contract to deliver nearly 1.7 million courses of
White House Backs Merck-J&J Vaccine Manufacturing CollaborationNews

White House Backs Merck-J&J Vaccine Manufacturing Collaboration

The Biden administration is supporting collaboration between Johnson & Johnson (NYSE: JNJ) and Merck (NYSE: MRK) to produce more COVID-19
Merck to Receive $356M US Gov’t Funds for COVID-19 Drug Manufacturing, SupplyContract Awards

Merck to Receive $356M US Gov’t Funds for COVID-19 Drug Manufacturing, Supply

Merck (NYSE: MRK) has reached a $356M deal with the departments of Defense and Health and Human Services to further…
Report: Civilian Agency Spending Reached $228B in FY 2020News

Report: Civilian Agency Spending Reached $228B in FY 2020

Contract spending across civilian government agencies increased to $228B during fiscal year 2020, Bloomberg Government reported Tuesday. BGOV data shows…
Former HHS Senior Adviser Andrew Sommers to Head Maximus’ Public Health GroupExecutive Moves

Former HHS Senior Adviser Andrew Sommers to Head Maximus’ Public Health Group

Maximus (NYSE: MMS) has appointed Andrew Sommers, formerly a senior policy adviser at the Department of Health and Human Services,…
Thoma Bravo to Acquire Cloud-Based Collaboration Tech Provider Exostar; Carl Press QuotedM&A Activity

Thoma Bravo to Acquire Cloud-Based Collaboration Tech Provider Exostar; Carl Press Quoted

Private equity firm Thoma Bravo has agreed to buy Exostar, a Herndon, Va.-based provider of cloud-based business collaboration platforms for aerospace…
October 3 Market Close: GovCon Index Stuck in Neutral on S&P Stocks’ Gains,  KBR and McKesson DeclinesFinancial Report

October 3 Market Close: GovCon Index Stuck in Neutral on S&P Stocks’ Gains, KBR and McKesson Declines

Executive Mosaic’s GovCon Index closed flat Monday to start the year’s fourth quarter as a rebound by Vectrus (NYSE: VEC) in conjunction